LAPLACE: TIMI 57 - A Double-Blind, Randomized, Placebo-controlled, Multicenter, Dose- ranging Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Combination with HMG-CoA Reductase Inhibitorsin Hypercholesterolemic Subjects

  • Bailey, Alison (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/24/116/30/16